Mark A. Morris
35Patents
8h-index
67Co-inventors
78Inventor score
Filing activity: Aug 5, 2003 → Feb 27, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9376448B2 | DNA-PK inhibitors | Chemistry; Metallurgy | 44 | Active |
| US9925188B2 | DNA-PK inhibitors and uses thereof | Chemistry; Metallurgy | 20 | Active |
| US9359380B2 | DNA-PK inhibitors | Chemistry; Metallurgy | 18 | Active |
| US9340557B2 | Substituted quinoxaline DNA-PK inhibitors | Chemistry; Metallurgy | 18 | Active |
| US9296701B2 | DNA-PK inhibitors | Chemistry; Metallurgy | 18 | Active |
| US9592232B2 | DNA-PK inhibitors | Chemistry; Metallurgy | 17 | Active |
| US7179822B2 | Hetero biaryl derivatives as matrix metalloproteinase inhibitors | Chemistry; Metallurgy | 10 | Expired |
| US9878993B2 | DNA-PK inhibitors for treatment of cancer | Chemistry; Metallurgy | 8 | Active |
| US8354419B2 | Benzimidazole analogues for the treatment or prevention of flavivirus infections | Chemistry; Metallurgy | 7 | Active |
| US10076521B2 | DNA-PK inhibitors | Chemistry; Metallurgy | 6 | Active |
| US8779156B2 | Analogues for the treatment or prevention of flavivirus infections | Chemistry; Metallurgy | 6 | Active |
| US9987284B2 | Substituted benzooxadiazole DNA-PK inhibitors | Chemistry; Metallurgy | 5 | Active |
| US10258627B2 | DNA-PK inhibitors | Chemistry; Metallurgy | 4 | Active |
| US10183036B2 | Use of nicotinic acid riboside or nicotinamide riboside derivatives, and reduced derivatives thereof, as NAD+ increasing precursors | Human Necessities | 4 | Active |
| US10442791B2 | DNA-PK inhibitors | Chemistry; Metallurgy | 4 | Active |
| US10391095B2 | DNA-PK inhibitors | Chemistry; Metallurgy | 4 | Active |
| US10501439B2 | DNA-PK inhibitors | Chemistry; Metallurgy | 4 | Active |
| US8044052B2 | Biaryl ether urea compounds | Chemistry; Metallurgy | 3 | Active |
| US10786512B2 | DNA-PK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US10973830B2 | Substituted quinoxaline DNA-PK inhibitors | Chemistry; Metallurgy | 2 | Active |
| US12043616B2 | Crystalline forms of nicotinamide riboside chloride | Chemistry; Metallurgy | 2 | Active |
| US11389468B2 | Nicotinamide riboside for use in treating or preventing liver damage | Emerging Cross-Sectional Technologies | 1 | Active |
| US11414407B2 | Crystalline forms of nicotinamide riboside chloride | Chemistry; Metallurgy | 1 | Active |
| US11129843B2 | Treating and preventing kidney damage | Human Necessities | 0 | Active |
| US11524022B2 | Use of nicotinamide riboside, nicotinic acid riboside, and nicotinamide mononucleotide, reduced nicotinyl compounds, and nicotinoyl compound derivatives in infant formula for healthy development | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.